<DOC>
	<DOCNO>NCT00662610</DOCNO>
	<brief_summary>To assess effect naproxcinod vs. naproxen arterial blood pressure patient osteoarthritis control essential hypertension</brief_summary>
	<brief_title>A Study Assess Effects Naproxcinod Naproxen Blood Pressure Measurements Osteoarthritis Patients With Controlled High Blood Pressure</brief_title>
	<detailed_description>This 12-week , randomize , double-blind , multicenter study compare effect naproxcinod naproxen 24 hour arterial blood pressure profile . Patients randomly allocate different naproxcinod naproxen dose 1:1 ratio .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Naproxen-n-butyl nitrate</mesh_term>
	<criteria>Men/Women , 40 old , diagnose hip knee Osteoarthritis . Hypertensive patient treat controlled essential hypertension . Must receive least one antihypertensive treatment follow drug class : Diuretic , AngiotensinConverting Enzyme ( ACE ) inhibitor , Angiotensin Receptor Blocker ( ARB ) BetaBlocker ( BB ) . Must current chronic user NSAIDS acetaminophen . Must discontinue analgesic therapy Screening . More two different class antihypertensive drug . Uncontrolled diabetes . Hepatic renal impairment . A history alcohol/drug abuse . Diagnosis gastric duodenal ulceration and/or history significant gastroduodenal bleeding . History congestive heart failure . Clinically relevant abnormal ECG . Current expect use anticoagulant . Current history medical disease could interfere study objective put patient 's safety risk . Participation within 30 day prior prescreening another investigational study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>